Skip to main content
Clinical Trials/NCT06349005
NCT06349005CompletedNot Applicable

Hemodynamic Response to Various Laryngoscopes During Tracheal Intubation in CABG Patients

Konya Meram State Hospital1 site in 1 country112 target enrollmentStarted: January 12, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
112
Locations
1
Primary Endpoint
Hemodynamic response

Study Overview

Brief Summary

In this prospective, randomized, controlled trial, the purpose is to compare Macintosh laryngoscope, EzVision® video laryngoscope, McGrath® video laryngoscope and Storz® video laryngoscope in terms of hemodynamic response associated with intubation in adult patients undergoing Coronary Artery Bypass Surgery (CABG).

Detailed Description

During endotracheal intubation, laryngoscopy can significantly affect hemodynamic responses, including tachycardia and elevated blood pressure, which may be particularly detrimental to individuals with cardiovascular conditions. Various studies have explored the hemodynamic reactions associated with laryngeal stimulation through different intubation devices. Researchers hypothesize that endotracheal intubation using video laryngoscopy will elicit a reduced hemodynamic response compared to traditional (Macintosh) laryngoscopy. In this prospective and randomized clinical study, the purpose is to compare the Macintosh laryngoscope, EzVision® video laryngoscope, McGrath® video laryngoscope and Storz® video laryngoscope concerning haemodynamic response associated with intubation in adult patients undergoing Coronary Artery Bypass Surgery (CABG).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Age range between 18 and 75 years.
  • •Scheduled for elective coronary artery bypass surgery.
  • •Classified under American Society of Anesthesiologists (ASA) physical status II-III.
  • •Patients with no history of difficult intubation or associated risk factors.

Exclusion Criteria

  • •Emergency case
  • •Predicted difficult airways
  • •Body mass index > 35 kilograms per meter squared
  • •Baseline hemodynamic instability

Arms & Interventions

Group Storz VL

Active Comparator

Patients will undergo intubation with the Storz Videolaryngoscope®, during which their hemodynamic responses will be documented.

Intervention: Tracheal intubation using Storz VL (Other)

Group MacGrath VL

Active Comparator

Patients will undergo intubation with the McGrath Videolaryngoscope®, during which their hemodynamic responses will be documented.

Intervention: Tracheal intubation using MacGrath VL (Other)

Group EzVision VL

Active Comparator

Patients will undergo intubation with the EzVision Videolaryngoscope®, during which their hemodynamic responses will be documented.

Intervention: Tracheal intubation using EzVision VL (Other)

Group Traditional

Active Comparator

Patients will undergo intubation with the traditional (Macintosh) laryngoscopy, during which their hemodynamic responses will be documented.

Intervention: Tracheal intubation using Macintosh laryngoscopy (Other)

Outcomes

Primary Outcomes

Hemodynamic response

Time Frame: Change from baseline heart rate at 10 minutes

Change from baseline heart rate

Hemodynamic response

Time Frame: Change from baseline Systolic or Diastolic or mean Blood Pressure at 10 minutes

Change from baseline invasive blood pressure

Secondary Outcomes

  • Intubation time(180 seconds)
  • Visualization of the glottis(180 seconds)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Betul Kozanhan

Prof. Dr

Konya Meram State Hospital

Study Sites (1)

Loading locations...

Similar Trials